| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/12/2010 | EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 05/12/2010 | EP2183224A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
| 05/12/2010 | EP2183223A2 Metabolites and derivatives of ambrisentan |
| 05/12/2010 | CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 05/12/2010 | CN101704810A Cycloalkyl inhibitors of potassium channel function |
| 05/12/2010 | CN101704797A compounds effecting glucokinase |
| 05/12/2010 | CN101704791A Method for synthesizing 1H,3H-quinazoline-2,4-diketone |
| 05/12/2010 | CN101704790A Phytocidal N-uracil-substituted phenyl aryloxy-alkyl amide compound |
| 05/12/2010 | CN101041636B Method for synthesizing heterocyclic ketenes amine condensation derivatives |
| 05/11/2010 | US7714138 Monocyclic heterocycles as kinase inhibitors |
| 05/11/2010 | US7714115 18-F labelled positron emission tomography tracer compounds such as [18F]-fluorodeoxyglucose; autoclaving; microfluidics; solid phase synthesis; solution phase synthesis |
| 05/11/2010 | US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/11/2010 | US7713988 use for lowering blood glucose, treating diabetes, or increasing insulin release; 7-(4,5-Diphenylpyrimidin-2-yl)-6-heptynoic Acid |
| 05/11/2010 | US7713983 Voltage gated sodium and calcium channel inhibitors |
| 05/11/2010 | US7713981 Method and compounds for inhibition of cell death |
| 05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
| 05/11/2010 | US7713900 5,5'-bis(disubstitutedphosphino)-1,1',3,3'-tetraalkyl-4,4'-bipyrimidine-2,2',6,6'-(1H,1'H,3H,3'H)-tetrone used as as ligands to generate chiral transition metal catalysts, for asymmetric allylic substitution reactions |
| 05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
| 05/11/2010 | CA2413134C Quinazoline ditosylate salt compounds |
| 05/11/2010 | CA2399089C Process for exchanging functional groups by halogen-metal exchange reaction |
| 05/11/2010 | CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 05/11/2010 | CA2326324C Nitrogen-containing heterocyclic compound |
| 05/11/2010 | CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 05/06/2010 | WO2010051188A1 P2x3, receptor antagonists for treatment of pain |
| 05/06/2010 | WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 05/06/2010 | US20100113774 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 05/06/2010 | US20100113491 Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 05/06/2010 | US20100113490 Substituted Pyrimidine Ether Compounds and use thereof |
| 05/06/2010 | US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 05/06/2010 | US20100113480 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists |
| 05/06/2010 | US20100113479 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists |
| 05/06/2010 | US20100113477 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof |
| 05/06/2010 | US20100113468 Quinazoline derivatives as kinase inhibitors |
| 05/06/2010 | US20100113467 Organic Compounds |
| 05/06/2010 | US20100113460 Organic Compounds |
| 05/06/2010 | US20100113445 Chemical Compounds |
| 05/06/2010 | US20100113444 Prolyl hydroxylase inhibitors |
| 05/06/2010 | US20100113413 MAPK/ERK Kinase Inhibitors |
| 05/06/2010 | US20100113391 Bicyclic heterocyclic compound |
| 05/06/2010 | US20100113359 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity |
| 05/06/2010 | US20100113276 Use of n2-phenylamidines as herbicides |
| 05/06/2010 | US20100108949 Perimidine-substituted squarylium dye, dispersion medium, detection medium and image forming material |
| 05/06/2010 | CA2741666A1 P2x3, receptor antagonists for treatment of pain |
| 05/05/2010 | EP2181099A2 Crystalline forms of erlotinib hcl and formulations thereof |
| 05/05/2010 | EP2181098A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
| 05/05/2010 | EP2181094A1 Fluorine-containing organosulfur compound and pesticidal composition thereof |
| 05/05/2010 | EP1987012B1 Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine |
| 05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 05/05/2010 | EP1411993B1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 05/05/2010 | CN1958593B Method for preparing intermediate of synthesizing rosuvastatin calcium |
| 05/05/2010 | CN1769285B Doxazosin salt with optical activity |
| 05/05/2010 | CN1666983B Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same |
| 05/05/2010 | CN101701016A N-methyl-N-o-benzoyl aminobenzene formamide compounds as well as preparation and application thereof |
| 05/05/2010 | CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases |
| 05/05/2010 | CN101048387B Process for the preparation of phenyl 2-pyrimidinyl ketones and their novel intermediates |
| 05/04/2010 | US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 05/04/2010 | US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 05/04/2010 | US7709494 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 05/04/2010 | US7709492 Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| 05/04/2010 | US7709491 {8-Fluoro-2-(4'-fluoro-1,1'-biphenyl-4-yl)-3-[3-trifluoromethyl)phenyl]-3,4-dihydro-4-quinazolinyl}acetic acid; have high antiviral activity |
| 05/04/2010 | US7709490 use for lowering blood glucose, treating diabetes, or increasing insulin release; 7-(4,5-Diphenylpyrimidin-2-yl)-6-heptynoic Acid |
| 05/04/2010 | US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer |
| 05/04/2010 | CA2476587C Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 05/04/2010 | CA2399196C Pyrimidine compounds |
| 05/04/2010 | CA2282439C Formulations for hydrophobic pharmaceutical agents |
| 04/29/2010 | WO2010047774A2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof |
| 04/29/2010 | WO2010047712A1 Process for the preparation of substituted phenylalanines |
| 04/29/2010 | WO2010047260A1 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
| 04/29/2010 | WO2010046035A1 Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine |
| 04/29/2010 | WO2010046034A1 Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine |
| 04/29/2010 | WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105900 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
| 04/29/2010 | US20100105712 Chemical compounds |
| 04/29/2010 | US20100105693 Modulators of Muscarinic Receptors |
| 04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
| 04/29/2010 | US20100105674 Chemical Compounds |
| 04/29/2010 | US20100105668 Quinazoline derivatives |
| 04/29/2010 | US20100105659 2-aminopyridine analogs as glucokinase activators |
| 04/29/2010 | US20100105654 Substituted quinazolinone compounds |
| 04/29/2010 | US20100105562 Crystalline Form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide |
| 04/29/2010 | US20100105030 Nucleic acid base pairs |
| 04/29/2010 | CA2741563A1 Process for the preparation of substituted phenylalanines |
| 04/29/2010 | CA2740616A1 Sulphone-substituted anilinopyrimidine derivatives as cdk inhibitors, their preparation and use as medicaments |
| 04/29/2010 | CA2739739A1 Sulfoximine-substituted anilino-pyrimidine derivatives as cdk inhibitors, production and use thereof as medicinal products |
| 04/28/2010 | EP2179993A1 Sulfoxide substituted aniline pyrimidine derivatives as CDK inhibitors, their manufacture and use as medicine |
| 04/28/2010 | EP2179992A1 Sulfon substituted aniline pyrimidine derivatives as CDK inhibitors, their manufacture and use as medicine |
| 04/28/2010 | EP2179991A1 Sulfoximine substituted aniline pyrimidine derivatives as CDK inhibitors, their manufacture and use as medicine |
| 04/28/2010 | EP2179984A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 04/28/2010 | EP2178847A2 Process for preparing pyrimidine derivatives |
| 04/28/2010 | EP2178846A1 Rosuvastatin intermediates and their preparation |
| 04/28/2010 | EP2178840A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 04/28/2010 | EP2178837A2 Isophthalamide derivatives inhibiting beta-secretase activity |
| 04/28/2010 | EP1888536B1 Process for preparing substituted pyrimidines |